My Opinion | Nov 16,2019
Jun 8 , 2024
By Mariana Mazzucato
The COVID-19 pandemic illustrated how crucial public investment is in health innovation. The development of vaccines, backed by 31.9 billion dollars in US public investment, illustrates this. In this commentary provided by Project Syndicate (PS), Mariana Mazzucato (PhD), a founding director of the UCL Institute for Innovation & Public Purpose, and chair of the World Health Organization’s (WHO) Council on the Economics of Health for All, argued that the benefits must be governed for the common good, ensuring health products are accessible and affordable worldwide.
The world urgently needs a new global framework that emphasises equity and draws on the lessons of the COVID-19 pandemic. Yet, member states’ failure to meet their deadline for a pandemic agreement looms large. Still, this year’s gathering offers some cause for hope, because member states will vote on a resolution on the “Economics of Health for All,” which is deeply informed by the work of the World Health Organization’s (WHO) Council on the Economics of Health for All, which I chaired.
If the resolution passes, the WHO will be mandated to implement the Council's recommendations through its work with member states. Highlighting the linkages between health and the economy, it identifies specific steps the organisation and governments can take to prioritise health and well-being in cross-cutting policymaking. The Council called on governments worldwide to invest in health for "all" and to organise economic systems that value, finance, innovate for, and build capacity to achieve this goal.
Shaping our economies to reflect the goal of "health for all" is crucial to preventing or responding faster to future pandemics. But, it requires aligning health, economic, social, and environmental policy objectives. While it is health ministers who will vote at this assembly, they should not be seen as the only ones responsible. Health for all requires a whole-of-government approach, and especially attention from ministers of finance and economic policy.
This is particularly true today.
The resolution urges member states to frame health spending as a long-term investment, not a short-term cost. But austerity has returned to many countries, threatening health budgets already under pressure from debt-servicing costs and inflation. This is not merely a point about messaging. Investments in health are, in fact, long-term drivers of growth. The debt-to-GDP metric is a ratio: If governments focus on cutting debt (the numerator) and eschew investments promoting future growth (the denominator), the ratio will not decrease, and may even rise.
Fortunately, industrial policy is back in favour around the world, offering governments an opportunity to orient their growth strategies around health and other critical priorities. Instead of focusing on select sectors or technologies, a modern industrial strategy should focus on bold social and environmental missions, catalysing investment, innovation, and growth across relevant segments of the economy.
Innovation is based on collective intelligence; it does not emerge spontaneously from just one company. Around the world, health innovation benefits massively from public investment. The mRNA COVID-19 vaccines were supported by about 31.9 billion dollars in US public investment. They represent just one example among many.
However, the benefits may not be widely shared unless innovation is governed for the common good. We will need a new approach to public-private collaboration to ensure proper sharing of risks and rewards. Governments should set stronger conditions for those seeking public support for health innovation, not least by requiring that health products and services be widely available and affordable.
The problem is that the pharmaceutical industry’s lobbying continues to limit the strength of these conditions. In the ongoing pandemic treaty negotiations, for example, special interests have managed to block important measures related to intellectual property rights.
These rights should not be structured to protect monopoly profits or to inhibit access to vital health innovations – for example, by blocking timely and affordable production or withholding knowledge and technology transfers. In a health emergency like a pandemic, everyone – and every economy – ultimately suffers if equitable access to tests, vaccines, and lifesaving health products is not a top priority. In the case of COVID-19, an estimated 14 million people died, and the global economy lost about 14 trillion dollars.
The negotiation of the pandemic agreement shows the necessity of designing policy instruments in a mission-oriented way. If the goal is to prevent catastrophic health threats, the agreement must be oriented around this goal. And that means emphasising equity. This is also true for the design of global finance. Low- and middle-income countries need fiscal space to make critical investments in health. The pandemic agreement makes some reference to the importance of debt-relief measures.
But, a much stronger commitment is required – in line with the demands of the Bridgetown Initiative, spearheaded by Barbadian Prime Minister Mia Mottley – to reform multilateral development banks. These reforms need to ensure that countries have access not only to the right quantity but also the right quality of finance and are not hampered by unsustainable debt from making critical, long-term investments in health, climate, and economic priorities.
The pandemic may be waning, but the world is still confronting multiple, interrelated crises related to health, climate, and rising inequality within and between countries. We are failing to heed the lessons of the past four years. Climate change ensures that outbreaks will become more frequent, yet funding for epidemic preparedness and response remains insufficient. Rather than pursuing economic growth regardless of the consequences, we should orient economic activity toward human health and well-being goals and toward ensuring a healthy and sustainable environment.
We must escape the deeply flawed economic thinking that allowed the COVID-19 pandemic to become as bad as it did.
Implementing such an economy is not a luxury aspiration. It is a necessity if we are going to avoid the human – and economic – costs of another pandemic. Beyond adopting the resolution, this will require leadership from the WHO and member-state delegates. If health for all is going to become a top priority – as it must – it should be reflected fully in the design of public finance structures and economic, industrial, and innovation policies.
PUBLISHED ON
Jun 08,2024 [ VOL
25 , NO
1258]
My Opinion | Nov 16,2019
Fortune News | Sep 22,2024
Sunday with Eden | Mar 23,2019
Radar | Mar 06,2021
Life Matters | Jul 10,2021
Radar | Aug 04,2024
Radar | Jul 24,2023
Fortune News | Dec 19,2021
Viewpoints | Feb 25,2023
Viewpoints | Sep 01,2024
My Opinion | 111736 Views | Aug 14,2021
My Opinion | 108070 Views | Aug 21,2021
My Opinion | 106762 Views | Sep 10,2021
My Opinion | 104822 Views | Aug 07,2021
Aug 18 , 2024 . By AKSAH ITALO
Although predictable Yonas Zerihun's job in the ride-hailing service is not immune to...
Jul 13 , 2024 . By AKSAH ITALO
Investors who rely on tractors, trucks, and field vehicles for commuting, transportin...
Jul 13 , 2024 . By MUNIR SHEMSU
The cracks in Ethiopia's higher education system were laid bare during a synthesis re...
Jul 13 , 2024 . By AKSAH ITALO
Construction authorities have unveiled a price adjustment implementation manual for s...
Oct 12 , 2024
In his inaugural address on October 27, 2024, Taye Atseqesellasie, the fifth presiden...
Oct 5 , 2024
Not long ago, the sight of exchange bureaus in Addis Abeba was as rare as a cloudless...
Sep 28 , 2024
In the early 2010s, Ethiopian authorities found themselves at odds with the Internati...
Sep 21 , 2024
A nurse in Addis Abeba shares a cramped one-room apartment with three colleagues. Her...
Oct 13 , 2024
A new directive by the Central Bank requiring coffee exporters to convert half of the...
Oct 13 , 2024 . By AKSAH ITALO
The National Bank of Ethiopia (NBE) is heightening its regulatory oversight of microf...
Despite a substantial boost in budget and import volumes, farmers may contend with fe...
Fuel prices have spiked, exacerbated by global supply disruptions and a weakening Bir...